secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001437749-23-032491
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics establishes $50M ATM equity sales program
------------------------------------------------------------------

- Entered into at-market issuance agreement with Oppenheimer, B. Riley, and JonesTrading on Nov 17, 2023.
- May offer and sell up to $50,000,000 of common stock from time to time at the market.
- Agents receive 3.0% commission on gross proceeds from sales effectuated through them.
- Program is under a new S-3 registration statement (File No. 333-275638) filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/0001437749-23-032491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/isr20231117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-032491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer